These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 13471599)

  • 21. MICROCOAGULATION IN SHOCK.
    HARDAWAY RM
    Am J Surg; 1965 Sep; 110():298-301. PubMed ID: 14337977
    [No Abstract]   [Full Text] [Related]  

  • 22. The in vivo effect of fibrinogen and factor XIII on clot formation and fibrinolysis in Glanzmann's thrombasthenia.
    Shenkman B; Livnat T; Misgav M; Budnik I; Einav Y; Martinowitz U
    Platelets; 2012; 23(8):604-10. PubMed ID: 22273510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [NEUTRALIZATION OF ANTIPLASMIN IN THE BLOOD DURING PROTECTIVE REACTIONS OF THE PHYSIOLOGIC ANTICOAGULATION SYSTEM].
    KUDRIASHOV BA; ANDREENKO GV; KALISHEVSKAIA TM
    Probl Gematol Pereliv Krovi; 1964 Apr; 9():12-5. PubMed ID: 14195816
    [No Abstract]   [Full Text] [Related]  

  • 24. A synthetic analog of fibrinogen alpha 27-50 is an inhibitor of thrombin.
    Binnie CG; Lord ST
    Thromb Haemost; 1991 Feb; 65(2):165-8. PubMed ID: 2053103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A simple means to determine exact moment of clotting in prothrombin or thrombin time determination.
    HONORATO R
    Proc Soc Exp Biol Med; 1947 May; 65(1):41. PubMed ID: 20243114
    [No Abstract]   [Full Text] [Related]  

  • 26. Rational and timely haemostatic interventions following cardiac surgery - coagulation factor concentrates or blood bank products.
    Tang M; Fenger-Eriksen C; Wierup P; Greisen J; Ingerslev J; Hjortdal V; Sørensen B
    Thromb Res; 2017 Jun; 154():73-79. PubMed ID: 28437748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The reducing properties of fibrinogen; the role of SH groups in the clotting of fibrinogen.
    BAGDY D; GUBA F
    Hung Acta Physiol; 1948; 1(6):197-210. PubMed ID: 18894927
    [No Abstract]   [Full Text] [Related]  

  • 29. DIFFERENCES IN THE CLOTTING OF LAMPREY FIBRINOGEN BY LAMPREY AND BOVINE THROMBINS.
    DOOLITTLE RF
    Biochem J; 1965 Mar; 94(3):735-41. PubMed ID: 14340065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alkaloids of tobacco and blood coagulation: effect of nicotine on thrombin and fibrinogen.
    Singh JM; Singh MD
    Clin Toxicol; 1975; 8(1):43-52. PubMed ID: 1137933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Action of thrombin in the clotting of fibrinogen.
    BAILEY K; BETTELHEIM FR; LORAND L; MIDDLEBROOK WR
    Nature; 1951 Feb; 167(4241):233-4. PubMed ID: 14806439
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of bile salts on fibrinogen and its clotting.
    MIHALYI E
    Hung Acta Physiol; 1948; 1(6):179-91. PubMed ID: 18894925
    [No Abstract]   [Full Text] [Related]  

  • 33. Influence of polyhydric alcohols on the clotting of fibrinogen.
    FERRY JD; SHULMAN S
    Fed Proc; 1948 Mar; 7(1 Pt 1):154. PubMed ID: 18856441
    [No Abstract]   [Full Text] [Related]  

  • 34. Determination of Fibrinogen and Thrombin Time (TT).
    Undas A
    Methods Mol Biol; 2017; 1646():105-110. PubMed ID: 28804822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous thrombin infusion leads to a bleeding phenotype in sheep.
    Siller-Matula JM; Miller I; Gemeiner M; Plasenzotti R; Bayer G; Mesteri I; Fabry A; Petroczi K; Nöbauer K; Razzazi-Fazeli E; Planchon S; Renaut J; Quehenberger P; Selzer E; Jilma B
    Thromb Res; 2012 Aug; 130(2):226-36. PubMed ID: 22289207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. THE EFFECT OF HEPARIN, HEPARINOIDS, AND OTHER ELECTRONEGATIVE COMPOUNDS ON THE IN VITRO THROMBIN-FIBRINOGEN CONVERSION AND ON WHOLE BLOOD CLOTTING TIME.
    SALAFSKY B; LOOMIS TA
    Arch Int Pharmacodyn Ther; 1964 Jul; 150():107-17. PubMed ID: 14204484
    [No Abstract]   [Full Text] [Related]  

  • 37. [Time of fibrinogen-fibrin conversion in normal blood clotting].
    BRAUNSTEINER H; REIMER EE
    Wien Z Inn Med; 1950 Oct; 31(10):375-7. PubMed ID: 14798856
    [No Abstract]   [Full Text] [Related]  

  • 38. Transformation of fibrinogen into fibrin. III. Kinetics of the pH change associated with the clotting of fibrinogen.
    MIHALYI E; BILLICK IH
    Biochim Biophys Acta; 1963 Apr; 71():97-108. PubMed ID: 13935712
    [No Abstract]   [Full Text] [Related]  

  • 39. Radiation-induced alteration of fibrinogen clotting rate and clot lability.
    RIESER P
    Proc Soc Exp Biol Med; 1956 Apr; 91(4):654-7. PubMed ID: 13323035
    [No Abstract]   [Full Text] [Related]  

  • 40. Clotting time and reaction velocity in the interaction of bovine fibrinogen and thrombin.
    WAUGH DF; LIVINGSTONE BJ
    Science; 1951 Feb; 113(2927):121-4. PubMed ID: 14798397
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.